loadpatents
name:-0.034047842025757
name:-0.0055229663848877
name:-0.00046014785766602
Doshi; Shivang Patent Filings

Doshi; Shivang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Doshi; Shivang.The latest application filed is for "methods and compositions for treating solid tumors and other malignancies".

Company Profile
0.7.15
  • Doshi; Shivang - Brookline MA
  • Doshi; Shivang - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and compositions for treating solid tumors and other malignancies
App 20180207163 - Borland; Maria ;   et al.
2018-07-26
Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer
Grant 10,010,552 - Kim , et al. July 3, 2
2018-07-03
Pharmaceutical combination comprising binimetinib
Grant 9,867,825 - Caponigro , et al. January 16, 2
2018-01-16
Combination therapy
Grant 9,408,847 - Doshi , et al. August 9, 2
2016-08-09
Combination Therapy Comprising A CDK4/6 Inhibitor and a PI3K Inhibitor for Use in the Treatment of Cancer
App 20160136171 - Kim; Sunkyu ;   et al.
2016-05-19
Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer
Grant 9,271,988 - Kim , et al. March 1, 2
2016-03-01
Combination Comprising a Cyclin Dependent Kinase 4 or Cyclin Dependent Kinase (CDK4/6) Inhibitor for Treating Cancer
App 20160008367 - Borland; Maria ;   et al.
2016-01-14
Pharmaceutical Combination Comprising Binimetinib
App 20150313902 - CAPONIGRO; Giordano ;   et al.
2015-11-05
Combination Therapy
App 20150306104 - Doshi; Shivang ;   et al.
2015-10-29
Combination Therapy
App 20140113909 - Kim; Sunkyu ;   et al.
2014-04-24
Combination Therapy Comprising A CDK4/6 Inhibitor and a P13K Inhibitor for Use in the Treatment of Cancer
App 20140107114 - Kim; Sunkyu ;   et al.
2014-04-17
Combination Comprising A Cyclin Dependent Kinase 4 Or Cyclin Dependent Kinase (cdk4/6) Inhibitor For Treating Cancer
App 20130035336 - Borland; Maria ;   et al.
2013-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed